Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Canada

BC-Cancer Agency - Vancouver, Vancouver, British Columbia

Verspeeten Family Cancer Centre, London Health Sciences Centre, London, Ontario

Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec